Laura Jennings-Antipov is a Director of Commercial Developoment at Riffyn. Prior to joining the Riffyn team, Laura was a team member at Silver Creek Pharmaceuticals, a drug discovery company located in San Francisco. She joined Silver Creek as employee #4 and helped build a research program focused on developing targeted growth factors for regenerative medicine. Laura brings to Riffyn her expertise in assay development and experimental design as well as her experience in simplifying and communicating scientific concepts across disciplines. Laura received a Ph.D. in Biological Chemistry from MIT in 2008 and holds Bachelor's degrees in both Chemistry and Mathematics from the University of Missouri.